Navigation Links
Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development
Date:2/1/2010

EMERYVILLE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has appointed Ted W. Love, M.D., Executive Vice President and Head of Research and Development.  In addition, Michael Kauffman, M.D., Ph.D., who has served as Interim Chief Medical Officer since November 2009, has been appointed Chief Medical Officer reporting to Dr. Love.  

In his new role, Dr. Love will report to the Chief Executive Officer and will be responsible for managing the research and development organization, including preclinical and clinical programs, regulatory affairs, quality assurance and control, and safety.  Dr. Kauffman, in addition to partnering with Dr. Love across the company's portfolio, will continue to play a lead role in the clinical development of Onyx's pipeline of next-generation proteasome inhibitors, including carfilzomib, which is currently in a Phase 2b trial for relapsed, refractory multiple myeloma.

"Ted is a strategic thinker with broad leadership and management experience and a track record of developing some of the most successful cancer therapies, making him the ideal person to lead our research and development program of innovative oncology candidates," said N. Anthony Coles, M.D., President and Chief Executive Officer of Onyx.  "Together, Ted and Michael bring highly complementary experience that spans solid tumor and hematologic cancers, and multiple drug classes and molecular pathways.  These appointments empower Onyx with world class R&D leadership as we deliver on our vision to transform the lives of cancer patients and their families wi
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy
2. China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share
3. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
4. Peregrine Pharmaceuticals Appoints Dr. Marvin R. Garovoy as Head of Clinical Science
5. Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
6. China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base
7. China Yongxin Pharmaceuticals Projects Higher Net Income and EPS on Reduced Revenue for Full-Year 2009
8. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
9. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
10. Poniard Pharmaceuticals Announces $6.5 Million Financing
11. Titan Pharmaceuticals to Receive $3 Million Loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... oxide ceramics have potential uses as ferroelectrics, fast ... nuclear waste, generating a great deal of scientific ... these blended materials. , "The interfaces separating the ... radiation properties of the material as a whole," ... researcher on the project. "It is in the ...
(Date:9/23/2014)... 2014 Erlab , the expert ... 1968 and Burdinola, supplier of laboratory furniture solutions, announce ... fume hood. , By integrating Erlab’s ... will now offer an innovative solution utilizing the patented ... chemicals, best-in-class detection technology, and communication for security and ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 For the ... Inc. 500|5000 list of the fastest-growing companies. , ... been acknowledged yet again by Inc. Magazine,” ExakTime CEO Tony ... 5000 list by posting a three-year growth rate of 61 ... in that time by more than 40 percent. , Pappas ...
(Date:9/23/2014)... Sept. 23, 2014  Age Defying Dermatology ® , ... has become one of the first clinics in the ... aesthetic laser for tattoo removal. The treatment safely and ... "For years, tattoo removal has been a lengthy, painful, ... "This is an opportunity to erase tattoo pigment more ...
Breaking Biology Technology:Los Alamos researchers uncover properties in nanocomposite oxide ceramics for reactor fuel 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ExakTime Makes Inc. 5000 List for the Fifth Time 2Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2
... screening initiative launches in Atlanta and continues for 90 days;, ... in 13 cities ... across the country, ... specialty biopharmaceutical company, today,announced the launch of a 13-city mobile screening ...
... to Impact Lung Cancer Care, ST. LOUIS, ... start-up company, has secured $4.75M in venture capital ... delivery system for minimally,invasive biopsy and ablation of ... was joined by Advantage Capital Partners and existing ...
... EuroPCR08 will highlight choice of different modalities ... available on single integrated imaging platform., SAN DIEGO, ... VOLC ), a leading manufacturer and developer of,intravascular ultrasound ... designed to enhance the diagnosis and,treatment of coronary and ...
Cached Biology Technology:Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 2Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 3Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 4Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5Veran Medical Technologies Secures $4.75M in First Institutional Funding 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4
(Date:9/23/2014)... has domesticated animals, selecting the best traits possible ... an intriguing animal to examine adaptation to climate ... selected breeding and a wealth of livestock genome-wide ... study that combined molecular and environmental data, professor ... genes under environmental selection from domesticated sheep breeds. ...
(Date:9/23/2014)... at the University of Wisconsin-Madison and the Morgridge Institute ... to screen for neural toxins, helping flag chemicals that ... Health (NIH) announced today that the UW-Madison and Morgridge ... the promising work as part of the Tissue Chip ... $7 million over the three-year project. , The ...
(Date:9/23/2014)... new tissues during the healing process, cells must ... years, scientists believed this communication happened primarily through ... and the University of Pittsburgh have found that ... if not more crucial. The findings, published in ... the National Academy of Sciences , could lead ...
Breaking Biology News(10 mins):Being sheepish about climate adaptation 2UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3The mechanics of tissue growth 2
... anything they want and never gain a pound, while others ... You may be seeing things correctly after all. According ... Genetics ( http://www.genetics.org ), this may have a biological ... with diet, rather than diet alone, are the main cause ...
... (CLOTS)an intensive five-day course offered by the Society ... interventional radiologists, neurointerventionalists, vascular neurologists and fellows-in-training with ... discuss all aspects of acute stroke management. ... in the United States, with about 600,000 new ...
... Just as cooking helps people digest food, pretreating polycarbonate ... of its bisphenol A (BPA) content may be ... eco-friendly way, scientists have found. Their new study is ... Mukesh Doble and Trishul Artham note that manufacturers produce ...
Cached Biology News:Why fad diets work well for some, but not others 2Explore stroke care with Society of Interventional Radiology's CLOTS 2
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant PRKG1. NCBI Entrez Gene ID = PRKG1...
Biology Products: